Trial Profile
Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IMA-026 Administered Subcutaneously or Intravenously to Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Aug 2008
Price :
$35
*